DnB Asset Management
ALXN

DnB Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-32,063
Closed -$5.89M 660
2021
Q2
$5.89M Sell
32,063
-956,820
-97% -$176M 0.04% 336
2021
Q1
$151M Buy
988,883
+701,261
+244% +$107M 1.1% 17
2020
Q4
$44.9M Buy
287,622
+187,158
+186% +$29.2M 0.39% 43
2020
Q3
$11.5M Sell
100,464
-647,872
-87% -$74.1M 0.12% 132
2020
Q2
$84M Sell
748,336
-27,570
-4% -$3.09M 0.99% 19
2020
Q1
$69.7M Buy
775,906
+739,747
+2,046% +$66.4M 1.02% 18
2019
Q4
$3.91M Sell
36,159
-11,326
-24% -$1.22M 0.04% 289
2019
Q3
$4.65M Buy
47,485
+2,216
+5% +$217K 0.05% 252
2019
Q2
$5.93M Buy
45,269
+11,362
+34% +$1.49M 0.07% 206
2019
Q1
$4.58M Buy
33,907
+8,011
+31% +$1.08M 0.05% 232
2018
Q4
$2.52M Sell
25,896
-1,279
-5% -$125K 0.03% 325
2018
Q3
$3.78M Buy
27,175
+967
+4% +$134K 0.04% 275
2018
Q2
$3.25M Buy
26,208
+1,100
+4% +$137K 0.04% 285
2018
Q1
$2.8M Buy
25,108
+2,300
+10% +$256K 0.03% 305
2017
Q4
$2.73M Hold
22,808
0.03% 308
2017
Q3
$3.2M Hold
22,808
0.04% 262
2017
Q2
$2.78M Sell
22,808
-600
-3% -$73K 0.04% 274
2017
Q1
$2.84M Buy
23,408
+2,100
+10% +$255K 0.04% 268
2016
Q4
$2.61M Sell
21,308
-8,600
-29% -$1.05M 0.05% 243
2016
Q3
$3.66M Buy
29,908
+10,100
+51% +$1.24M 0.07% 196
2016
Q2
$2.31M Buy
19,808
+800
+4% +$93.4K 0.05% 243
2016
Q1
$2.65M Buy
19,008
+7,700
+68% +$1.07M 0.06% 229
2015
Q4
$2.16M Sell
11,308
-200
-2% -$38.2K 0.05% 226
2015
Q3
$1.8M Buy
11,508
+700
+6% +$109K 0.04% 229
2015
Q2
$1.95M Hold
10,808
0.04% 234
2015
Q1
$1.87M Sell
10,808
-300
-3% -$52K 0.04% 244
2014
Q4
$2.06M Buy
11,108
+1,100
+11% +$204K 0.05% 223
2014
Q3
$1.66M Buy
+10,008
New +$1.66M 0.04% 238